疫苗加强针能有效抑制新冠病毒奥密克戎变种的侵入。 - Suppr

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant.

作者信息

Zhang Wei, Huang Linfen, Ye Gang, Geng Qibin, Ikeogu Nwando, Harris Morgan, Dileepan Gayathri, Burrack Kristina, Du Lanying, Frosch Anne, Li Fang

机构信息

Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN, USA.

Center for Coronavirus Research, University of Minnesota, Saint Paul, MN, USA.

出版信息

Cell Mol Immunol. 2022 Mar;19(3):445-446. doi: 10.1038/s41423-022-00837-6. Epub 2022 Jan 24.

DOI:10.1038/s41423-022-00837-6

PMID:35075267

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8785151/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/945d/8891254/0da78ad23248/41423_2022_837_Fig1_HTML.jpg

相似文献

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant.

Cell Mol Immunol. 2022 Mar;19(3):445-446. doi: 10.1038/s41423-022-00837-6. Epub 2022 Jan 24.

Omicron likely to weaken COVID vaccine protection.

Nature. 2021 Dec;600(7889):367-368. doi: 10.1038/d41586-021-03672-3.

Omicron sparks a vaccine strategy debate.

Science. 2021 Dec 24;374(6575):1544-1545. doi: 10.1126/science.acz9879. Epub 2021 Dec 23.

Could mixing COVID vaccines boost immune response?

Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.

Booster shots for COVID-19-the debate continues.

Lancet Infect Dis. 2021 Oct;21(10):1359-1360. doi: 10.1016/S1473-3099(21)00574-0.

Omicron: Call for updated vaccines.

J Med Virol. 2022 Apr;94(4):1261-1263. doi: 10.1002/jmv.27530. Epub 2021 Dec 28.

A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.

J Med Virol. 2022 Jan;94(1):35-38. doi: 10.1002/jmv.27334. Epub 2021 Sep 22.

Plasma Neutralization of the SARS-CoV-2 Omicron Variant.

N Engl J Med. 2022 Feb 10;386(6):599-601. doi: 10.1056/NEJMc2119641. Epub 2021 Dec 30.

COVID-19 vaccine breakthrough infections.

Science. 2021 Dec 24;374(6575):1561-1562. doi: 10.1126/science.abl8487. Epub 2021 Dec 23.

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.

N Engl J Med. 2022 Feb 3;386(5):492-494. doi: 10.1056/NEJMc2119358. Epub 2021 Dec 29.

引用本文的文献

Comparison of long-term anti-RBD SARS-CoV-2 antibody response following different vaccination schemes in Tunisia.

Tunis Med. 2024 Aug 5;102(8):457-464. doi: 10.62438/tunismed.v102i8.4944.

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.

Front Microbiol. 2024 Jun 13;15:1334152. doi: 10.3389/fmicb.2024.1334152. eCollection 2024.

Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants.

J Infect Dis. 2023 Jul 14;228(2):160-168. doi: 10.1093/infdis/jiad057.

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern.

NPJ Vaccines. 2022 Dec 19;7(1):169. doi: 10.1038/s41541-022-00580-z.

mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern.

iScience. 2022 Dec 22;25(12):105690. doi: 10.1016/j.isci.2022.105690. Epub 2022 Dec 1.

Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen.

J Infect Dis. 2023 Feb 14;227(4):528-532. doi: 10.1093/infdis/jiac432.

Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil.

Bioengineering (Basel). 2022 Oct 20;9(10):584. doi: 10.3390/bioengineering9100584.

Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention.

MedComm (2020). 2022 Aug 16;3(3):e172. doi: 10.1002/mco2.172. eCollection 2022 Sep.

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.

J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.

Nanotheranostics and its role in diagnosis, treatment and prevention of COVID-19.

Front Mater Sci. 2022;16(2):220611. doi: 10.1007/s11706-022-0611-y. Epub 2022 Aug 3.

本文引用的文献

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.

PLoS Pathog. 2021 Sep 7;17(9):e1009897. doi: 10.1371/journal.ppat.1009897. eCollection 2021 Sep.

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.

SARS-CoV-2 vaccines in development.

Nature. 2020 Oct;586(7830):516-527. doi: 10.1038/s41586-020-2798-3. Epub 2020 Sep 23.

Structure, Function, and Evolution of Coronavirus Spike Proteins.

Annu Rev Virol. 2016 Sep 29;3(1):237-261. doi: 10.1146/annurev-virology-110615-042301. Epub 2016 Aug 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant.

Cell Mol Immunol. 2022 Mar;19(3):445-446. doi: 10.1038/s41423-022-00837-6. Epub 2022 Jan 24.

Omicron likely to weaken COVID vaccine protection.

Nature. 2021 Dec;600(7889):367-368. doi: 10.1038/d41586-021-03672-3.

Omicron sparks a vaccine strategy debate.

Science. 2021 Dec 24;374(6575):1544-1545. doi: 10.1126/science.acz9879. Epub 2021 Dec 23.

Could mixing COVID vaccines boost immune response?

Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.

Booster shots for COVID-19-the debate continues.

Lancet Infect Dis. 2021 Oct;21(10):1359-1360. doi: 10.1016/S1473-3099(21)00574-0.

Omicron: Call for updated vaccines.

J Med Virol. 2022 Apr;94(4):1261-1263. doi: 10.1002/jmv.27530. Epub 2021 Dec 28.

A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.

J Med Virol. 2022 Jan;94(1):35-38. doi: 10.1002/jmv.27334. Epub 2021 Sep 22.

Plasma Neutralization of the SARS-CoV-2 Omicron Variant.

N Engl J Med. 2022 Feb 10;386(6):599-601. doi: 10.1056/NEJMc2119641. Epub 2021 Dec 30.

COVID-19 vaccine breakthrough infections.

Science. 2021 Dec 24;374(6575):1561-1562. doi: 10.1126/science.abl8487. Epub 2021 Dec 23.

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.

N Engl J Med. 2022 Feb 3;386(5):492-494. doi: 10.1056/NEJMc2119358. Epub 2021 Dec 29.

引用本文的文献

Comparison of long-term anti-RBD SARS-CoV-2 antibody response following different vaccination schemes in Tunisia.

Tunis Med. 2024 Aug 5;102(8):457-464. doi: 10.62438/tunismed.v102i8.4944.

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.

Front Microbiol. 2024 Jun 13;15:1334152. doi: 10.3389/fmicb.2024.1334152. eCollection 2024.

Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants.

J Infect Dis. 2023 Jul 14;228(2):160-168. doi: 10.1093/infdis/jiad057.

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern.

NPJ Vaccines. 2022 Dec 19;7(1):169. doi: 10.1038/s41541-022-00580-z.

mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern.

iScience. 2022 Dec 22;25(12):105690. doi: 10.1016/j.isci.2022.105690. Epub 2022 Dec 1.

Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen.

J Infect Dis. 2023 Feb 14;227(4):528-532. doi: 10.1093/infdis/jiac432.

Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil.

Bioengineering (Basel). 2022 Oct 20;9(10):584. doi: 10.3390/bioengineering9100584.

Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention.

MedComm (2020). 2022 Aug 16;3(3):e172. doi: 10.1002/mco2.172. eCollection 2022 Sep.

A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.

J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.

Nanotheranostics and its role in diagnosis, treatment and prevention of COVID-19.

Front Mater Sci. 2022;16(2):220611. doi: 10.1007/s11706-022-0611-y. Epub 2022 Aug 3.

本文引用的文献

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.

PLoS Pathog. 2021 Sep 7;17(9):e1009897. doi: 10.1371/journal.ppat.1009897. eCollection 2021 Sep.

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.

SARS-CoV-2 vaccines in development.

Nature. 2020 Oct;586(7830):516-527. doi: 10.1038/s41586-020-2798-3. Epub 2020 Sep 23.

Structure, Function, and Evolution of Coronavirus Spike Proteins.

Annu Rev Virol. 2016 Sep 29;3(1):237-261. doi: 10.1146/annurev-virology-110615-042301. Epub 2016 Aug 25.

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献